308 related articles for article (PubMed ID: 37978395)
1. Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.
Brennan K; Espín-Pérez A; Chang S; Bedi N; Saumyaa S; Shin JH; Plevritis SK; Gevaert O; Sunwoo JB; Gentles AJ
Genome Med; 2023 Nov; 15(1):98. PubMed ID: 37978395
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
3. SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma.
Feng S; Yuan W; Sun Z; Guo X; Ling J; Chang A; Zhao H; Zhuo X
J Oral Pathol Med; 2022 Aug; 51(7):620-629. PubMed ID: 35822409
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epithelial-mesenchymal transition of extracapsular spread tumors in lymph node metastases of head and neck cancer.
Lee WY; Shin DY; Kim HJ; Ko YH; Kim S; Jeong HS
Ann Surg Oncol; 2014 Jun; 21(6):1904-11. PubMed ID: 24566857
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer.
Ahn MH; Kim JH; Choi SJ; Kim HJ; Park DG; Oh KY; Yoon HJ; Hong SD; Lee JI; Shin JA; Cho SD
Cell Oncol (Dordr); 2024 Apr; 47(2):497-511. PubMed ID: 37787967
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptomics reveals the drivers and therapeutic targets of lymph node metastasis in lung adenocarcinoma.
Ji X; Wang Z; Wang G; Tang L; Han Z
Aging (Albany NY); 2023 Jul; 15(14):7023-7037. PubMed ID: 37487008
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.
Puram SV; Tirosh I; Parikh AS; Patel AP; Yizhak K; Gillespie S; Rodman C; Luo CL; Mroz EA; Emerick KS; Deschler DG; Varvares MA; Mylvaganam R; Rozenblatt-Rosen O; Rocco JW; Faquin WC; Lin DT; Regev A; Bernstein BE
Cell; 2017 Dec; 171(7):1611-1624.e24. PubMed ID: 29198524
[TBL] [Abstract][Full Text] [Related]
8. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
Dai Y; Wang Z; Yan E; Li J; Ge H; Xiao N; Cheng J; Diao P
Head Neck; 2022 Oct; 44(10):2171-2180. PubMed ID: 35726502
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Lymph Node Metastasis by Tumor Dimension Versus Tumor Biological Properties in Head and Neck Squamous Cell Carcinomas.
Jang JY; Kim MJ; Ryu G; Choi N; Ko YH; Jeong HS
Cancer Res Treat; 2016 Jan; 48(1):54-62. PubMed ID: 25761475
[TBL] [Abstract][Full Text] [Related]
11. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.
de Miranda MC; Melo MIA; Cunha PDS; Gentilini J; Faria JAQA; Rodrigues MA; Gomes DA
Biomed Pharmacother; 2021 Dec; 144():112269. PubMed ID: 34794230
[TBL] [Abstract][Full Text] [Related]
12. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
13. Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
Li H; Wang J; Li L; Zhao L; Wang Z
World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
[TBL] [Abstract][Full Text] [Related]
14. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
[TBL] [Abstract][Full Text] [Related]
15. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients.
Kropveld A; van Mansfeld AD; Nabben N; Hordijk GJ; Slootweg PJ
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):388-93. PubMed ID: 9039222
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma.
Moon JH; Lee SH; Lim YC
Clin Exp Metastasis; 2021 Apr; 38(2):163-174. PubMed ID: 33630219
[TBL] [Abstract][Full Text] [Related]
17. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
18. Potential oncogenic roles of mutant-p53-derived exosomes in the tumor-host interaction of head and neck cancers.
Azulay EE; Cooks T; Elkabets M
Cancer Immunol Immunother; 2020 Feb; 69(2):285-292. PubMed ID: 31897662
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals the heterogeneity of epithelial cell and fibroblast cells from non- to metastatic lymph node OTSCC.
Song D; Yang F; Sun Y; Wu X; Zhou Q; Bi W; Sun J; Li S; Yu Y
FASEB J; 2024 Jan; 38(1):e23390. PubMed ID: 38169064
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
